Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a Stoughton, Massachusetts-based biopharmaceutical company focused on central nervous system and pain conditions, has entered... Read More

The post Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program appeared first on citybiz.